Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Myeloproliferative neoplasms (MPNs) originate from genetically transformed hematopoietic stem cells that retain the capacity for multilineage differentiation and effective myelopoiesis. Beginning in early 2005, a number of novel mutations involving Janus kinase 2 (JAK2), Myeloproliferative Leukemia...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Tefferi, A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2010
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3035972/
https://ncbi.nlm.nih.gov/pubmed/20428194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2010.69
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller